Valeant Pharma (VRX) volatility spikes after Left said to take new short

Valeant Pharma (NYSE: VRX) July call option implied volatility is at 123, compared to closing level of 82 last night, August is at 94, compared to a closing level of 86, after Citron's Andrew Left said to take a new short stake and says worth $0.

You May Also Be Interested In

• Mosaic (MOS), Others Lower Following Trump Post on Potash from Belarus
• Black Hills Corp. (BKH) 3500 contracts of October 80 calls active, share price up 2.5%
• Trump approval falls to 32%, lowest ever - Reuters/Ipsos Poll